baclofen has been researched along with tizanidine in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (23.94) | 18.7374 |
1990's | 12 (16.90) | 18.2507 |
2000's | 18 (25.35) | 29.6817 |
2010's | 21 (29.58) | 24.3611 |
2020's | 3 (4.23) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Evans, RH; Long, SK; Siarey, RJ | 1 |
Milanov, IG | 1 |
Dietz, V | 1 |
Cerný, R; Jerábek, J; Krejcová, H; Vyskocilová, M | 1 |
Paulig, M; Pellkofer, M | 1 |
Ciblis, D; Medici, M; Pebet, M | 1 |
Rice, GP | 2 |
Klockgether, T; Schwarz, M; Sontag, KH; Turski, L; Wüllner, U | 1 |
Boisson, D; Eyssette, M; Rohmer, F; Serratrice, G; Warter, JM | 1 |
Bass, B; Bouchard, S; Cameron, MG; Ebers, GC; Hader, W; Noseworthy, JH; Rice, GP; Weinshenker, B | 1 |
Hoogstraten, MC; Minderhoud, JM; van der Ploeg, RJ; van Marle, S; vd Burg, W; Vreeling, A | 1 |
Nordal, HJ; Oftedal, SI; Slettebø, M; Stien, R | 1 |
Delwaide, PJ | 1 |
Davies, J | 1 |
McLellan, DL | 1 |
Davies, J; Johnston, SE | 1 |
Hudgson, P; Newman, PK; Newman, PM; Nogues, M; Weightman, D | 1 |
Muff, S; Smolenski, C; Smolenski-Kautz, S | 1 |
Corston, RN; Godwin-Austen, RB; Johnson, F | 1 |
Hassan, N; McLellan, DL | 1 |
Evans, RH; Long, SK; Siarey, RJ; Tulp, MT | 1 |
Davis, C; Emre, M; Groves, L; Lataste, X | 1 |
Skoog, B | 1 |
Brenner, R; Hyman, N; Knobler, R; O'Brien, M; Stephan, T | 1 |
Groves, L; Novack, GD; Shah, J; Shellenberger, MK | 1 |
Goodkin, DE; Kita, M | 1 |
Adone, R; Pagliacci, C; Taricco, M; Telaro, E | 1 |
Noth, J | 1 |
Autti-Rämö, I | 1 |
Schapiro, RT | 1 |
Rösche, J | 1 |
Anderson, PM; Lloyd, AC; Rushton, DN | 1 |
Al-Shahrani, AM | 1 |
Freitag, FG | 1 |
Yelnik, AP | 1 |
Das, SK; Guha, G; Misra, AK; Ray, BK | 1 |
Patel, DR; Soyode, O | 1 |
Adone, R; Pagliacci, MC; Taricco, M; Telaro, E | 1 |
He, L; Wu, B; Zhou, M | 1 |
Jacobs, BW; Saulino, M | 1 |
Awan, S; Dai, AI; Wasay, M | 1 |
Bensmail, D; Chaleat-Valayer, E; Decq, P; Dehail, P; Dumarcet, N; Marque, P; Parratte, B; Pellas, F; Quentin, V; Rousseaux, M; Simon, O; Trocello, JM; Uzzan, M; Yelnik, AP | 1 |
Benecke, R; Patejdl, R | 1 |
Kuks, JB; Lapeyre, E; Meijler, WJ | 1 |
Simon, O; Yelnik, AP | 1 |
Delgado, MR; Tilton, A; Vargus-Adams, J | 1 |
Chen, CL; Chung, CY; Wong, AM | 1 |
Heinzlef, O; Monteil-Roch, I | 1 |
Gillard, P; Graham, GD; Halpern, R; Varon, SF; Zorowitz, RD | 1 |
Chu, VW; Hornby, TG; Schmit, BD | 1 |
Chen, N; He, L; Yang, M; Zakrzewska, JM; Zhang, J; Zhou, M | 1 |
Lipták, J | 1 |
Aksoy, SN; Dai, AI; Demiryürek, AT | 1 |
Álvarez-Ossorio, L; Haupts, M; Jonas, A; Vila, C; Witte, K | 1 |
Comi, G; Gold, R; Hartung, HP; Montalban, X; Otero-Romero, S; Sastre-Garriga, J; Soelberg Sørensen, P; Thompson, AJ; Vermersch, P | 1 |
Kouzouna, A; Lindsay, C; Pandyan, AD; Simcox, C | 1 |
Achey, R; Bethoux, F; Dai, L; Jones, J; Lang, M; Lee, BS; Lobel, DA; Machado, AG; Nagel, SJ | 1 |
Fu, X; Li, J; Li, M; Ma, Q; Wang, C; Wang, Y; Wu, H; Yang, W | 1 |
Donato, AA; Hao, D; Olugbodi, A; Udechukwu, N | 1 |
Abouihia, A; Calabrese, A; Cloud, G; Creamer, M; Francisco, GE; Kossmehl, P; Saltuari, L; Ward, AB; Wissel, J; Yochelson, M; Zampolini, M | 1 |
Friedman, BW; Gallagher, EJ; Irizarry, E; Jones, MP; Pearlman, S; Shah, PD; Solorzano, C; Wollowitz, A; Zias, E | 1 |
Centonze, D; Comi, G; Leocani, L; Otero-Romero, S; Solari, A | 1 |
Jones, É; Vlachou, S | 1 |
Broder, BI; DiStasio, C; Hui, RL; Lee, EA; Niu, F; Steinberg, SG; Su Zhang, VR | 1 |
27 review(s) available for baclofen and tizanidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Spasticity: therapy of increased reflexes or movement disorder?].
Topics: Baclofen; Clonidine; Combined Modality Therapy; Dantrolene; Diazepam; Glycine; Humans; Locomotion; Muscle Relaxants, Central; Muscle Spasticity; Muscle Tonus; Muscles; Phenothiazines; Reflex, Abnormal | 1990 |
Pharmacotherapy of spasticity: some theoretical and practical considerations.
Topics: Baclofen; Benzodiazepines; Clonidine; Dantrolene; Humans; Muscle Spasticity; Parasympatholytics | 1987 |
Comparative profile of tizanidine in the management of spasticity.
Topics: Activities of Daily Living; Baclofen; Clonidine; Diazepam; Humans; Muscle Relaxants, Central; Muscle Spasticity; Muscle Tonus | 1994 |
An approach to switching patients from baclofen to tizanidine.
Topics: Baclofen; Clinical Competence; Clonidine; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Spinal Cord Diseases; Spinal Cord Injuries | 1998 |
Drugs used to treat spasticity.
Topics: Baclofen; Clonidine; Dantrolene; Diazepam; Drug Administration Schedule; Humans; Muscle Relaxants, Central; Muscle Spasticity | 2000 |
Pharmacological interventions for spasticity following spinal cord injury.
Topics: Baclofen; Clonidine; Dantrolene; Humans; Muscle Relaxants, Central; Parasympatholytics; Spasm; Spinal Cord Injuries | 2000 |
[Treatment of spasticity].
Topics: Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Clonidine; Humans; Injections, Spinal; Muscle Relaxants, Central; Muscle Spasticity; Neuromuscular Agents; Quality of Life | 1999 |
Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.
Topics: Acetates; Amines; Autoimmune Diseases; Baclofen; Benzodiazepines; Botulinum Toxins, Type A; Cannabinoids; Causalgia; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Dystonia; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Mechanoreceptors; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Pain; Physical Therapy Modalities; Receptors, GABA-A; Receptors, GABA-B; Relaxation Therapy; Trigeminal Neuralgia | 2001 |
Anti-spasticity medications.
Topics: Baclofen; Benzodiazepines; Botulinum Toxins, Type A; Clonidine; Humans; Muscle Relaxants, Central; Muscle Spasticity; Parasympatholytics | 2003 |
Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
Topics: Baclofen; Botulinum Toxins, Type A; Clonidine; GABA Agonists; Humans; Migraine Disorders; Muscle Relaxants, Central; Neuromuscular Agents; Tension-Type Headache | 2003 |
[Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics].
Topics: Arm; Baclofen; Botulinum Toxins, Type A; Clonidine; Combined Modality Therapy; Dantrolene; Ergonomics; Ethanol; Humans; Injections, Intramuscular; Injections, Spinal; Muscle Denervation; Muscle Spasticity; Neuromuscular Agents; Neuromuscular Blockade; Phenol; Physical Therapy Modalities; Stroke | 2004 |
Pharmacologic interventions for reducing spasticity in cerebral palsy.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Age Factors; Anti-Infective Agents, Local; Baclofen; Botulinum Toxins; Cerebral Palsy; Child; Child, Preschool; Clonidine; Dantrolene; Diazepam; Ethanol; Humans; Infant; Injections, Intramuscular; Injections, Spinal; Muscle Relaxants, Central; Muscle Spasticity; Neuromuscular Agents; Phenol; Time Factors | 2005 |
Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review.
Topics: Baclofen; Clonidine; Dantrolene; Humans; Muscle Relaxants, Central; Muscle Spasticity; Randomized Controlled Trials as Topic; Spinal Cord Injuries | 2006 |
Non-antiepileptic drugs for trigeminal neuralgia.
Topics: Amitriptyline; Baclofen; Carbamazepine; Clomipramine; Clonidine; Humans; Pimozide; Propoxycaine; Randomized Controlled Trials as Topic; Tocainide; Trigeminal Neuralgia | 2006 |
The pharmacological management of spasticity.
Topics: Baclofen; Clonidine; Dantrolene; Humans; Muscle Relaxants, Central; Muscle Spasticity | 2006 |
[New therapies for spastic movement disorders].
Topics: Administration, Oral; Baclofen; Botulinum Toxins, Type A; Cannabinoids; Clonidine; Diazepam; Humans; Injections, Intramuscular; Injections, Spinal; Movement Disorders; Muscle Relaxants, Central; Muscle Spasticity; Parasympatholytics; Physical Therapy Modalities; Tolperisone | 2009 |
Spasticity: revisiting the role and the individual value of several pharmacological treatments.
Topics: Amines; Baclofen; Botulinum Toxins; Calcium Channel Blockers; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diazepam; Gabapentin; gamma-Aminobutyric Acid; Humans; Muscle Relaxants, Central; Muscle Spasticity; Recovery of Function; Treatment Outcome | 2010 |
Managing spasticity with drugs.
Topics: Administration, Oral; Baclofen; Botulinum Toxins, Type A; Clonidine; Humans; Injections, Spinal; Muscle Relaxants, Central; Muscle Spasticity; Neuromuscular Agents | 2010 |
Pharmacologic treatment of spasticity in children.
Topics: Age Factors; Baclofen; Botulinum Toxins; Child; Clonidine; Dantrolene; Diazepam; Humans; Injections, Spinal; Muscle Spasticity; Neuromuscular Agents | 2010 |
Pharmacotherapy of spasticity in children with cerebral palsy.
Topics: Baclofen; Benzodiazepines; Cerebral Palsy; Child; Clonidine; Dantrolene; Humans; Muscle Spasticity; Neuromuscular Blocking Agents | 2011 |
[Pharmacological treatment of spasticity in multiple sclerosis].
Topics: Algorithms; Amines; Baclofen; Botulinum Toxins, Type A; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Double-Blind Method; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Humans; Infusion Pumps, Implantable; Injections, Spinal; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Nerve Block; Neuromuscular Agents; Randomized Controlled Trials as Topic; Spasm; Vigabatrin | 2012 |
Non-antiepileptic drugs for trigeminal neuralgia.
Topics: Amitriptyline; Analgesics; Anticonvulsants; Baclofen; Carbamazepine; Clomipramine; Clonidine; Humans; Pimozide; Propoxycaine; Randomized Controlled Trials as Topic; Tocainide; Trigeminal Neuralgia | 2013 |
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Topics: Amines; Analgesics; Baclofen; Cannabidiol; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diazepam; Dronabinol; Drug Combinations; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Spinal; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Phenol | 2016 |
Pharmacological interventions other than botulinum toxin for spasticity after stroke.
Topics: Baclofen; Botulinum Toxins, Type A; Clonidine; Diazepam; Humans; Muscle Relaxants, Central; Muscle Spasticity; Randomized Controlled Trials as Topic; Stroke; Tolperisone | 2016 |
A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: a systematic review and network meta-analysis.
Topics: Baclofen; Botulinum Toxins, Type A; Cannabinoids; Clonidine; Diazepam; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Neuromuscular Agents; Transcutaneous Electric Nerve Stimulation | 2018 |
A Critical Review of the Role of the Cannabinoid Compounds Δ
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Baclofen; Cannabidiol; Clinical Trials as Topic; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Approval; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Multiple Sclerosis; Spinal Cord; Treatment Outcome; United States; United States Food and Drug Administration | 2020 |
15 trial(s) available for baclofen and tizanidine
Article | Year |
---|---|
[Comparative double-blind study of the effectiveness and tolerance of baclofen, tetrazepam and tizanidine in spastic movement disorders of the lower extremities].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Baclofen; Benzodiazepines; Benzodiazepinones; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Random Allocation | 1989 |
A double-blind, long-term study of tizanidine ('Sirdalud') in spasticity due to cerebrovascular lesions.
Topics: Adult; Aged; Baclofen; Cerebrovascular Disorders; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Muscle Spasticity | 1989 |
Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis.
Topics: Adult; Aged; Baclofen; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity | 1988 |
Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis.
Topics: Adult; Aged; Baclofen; Brain; Clonidine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity | 1988 |
The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen.
Topics: Adult; Aged; Baclofen; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity | 1987 |
Tizanidine in the treatment of spasticity.
Topics: Adult; Baclofen; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscle Spasticity; Time Factors | 1982 |
A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
Topics: Adult; Aged; Baclofen; Chronic Disease; Clinical Trials as Topic; Clonidine; Double-Blind Method; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity | 1981 |
The assessment of drug treatment of spastic gait.
Topics: Aged; Baclofen; Clinical Trials as Topic; Clonidine; Female; Gait; Humans; Male; Middle Aged; Muscle Relaxants, Central; Muscle Spasticity | 1981 |
A controlled pharmacokinetic evaluation of tizanidine and baclofen at steady state.
Topics: Adrenergic alpha-Agonists; Adult; Area Under Curve; Baclofen; Biotransformation; Clonidine; Drug Interactions; Half-Life; Humans; Male; Muscle Relaxants, Central | 1999 |
Cost-effectiveness comparison of tizanidine and baclofen in the management of spasticity.
Topics: Baclofen; Clonidine; Cost-Benefit Analysis; Humans; Muscle Relaxants, Central; Muscle Spasticity; United Kingdom | 2002 |
Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Topics: Administration, Oral; Adolescent; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Chi-Square Distribution; Child; Child, Preschool; Clonidine; Drug Therapy, Combination; Equinus Deformity; Female; Humans; Male; Muscle Relaxants, Central; Neuromuscular Agents; Pilot Projects; Treatment Outcome | 2008 |
Effect of antispastic drugs on motor reflexes and voluntary muscle contraction in incomplete spinal cord injury.
Topics: Adult; Baclofen; Clonidine; Cross-Over Studies; Double-Blind Method; Electromyography; Humans; Isometric Contraction; Lower Extremity; Male; Middle Aged; Muscle Relaxants, Central; Muscle Strength; Pilot Projects; Reflex, Stretch; Spinal Cord Injuries; Torque | 2014 |
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Topics: Adult; Baclofen; Cannabidiol; Clonidine; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts | 2016 |
Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity.
Topics: Administration, Oral; Aged; Baclofen; Benzodiazepines; Clonidine; Dantrolene; Female; Humans; Infusions, Spinal; Male; Middle Aged; Muscle Relaxants, Central; Muscle Spasticity; Pain; Pain Measurement; Patient Satisfaction; Physical Therapy Modalities; Quality of Life; Severity of Illness Index; Stroke; Stroke Rehabilitation; Treatment Outcome | 2018 |
A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain.
Topics: Acute Pain; Adult; Analgesics, Non-Narcotic; Baclofen; Clonidine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ibuprofen; Low Back Pain; Male; Muscle Relaxants, Central; Oxazolidinones; Treatment Outcome | 2019 |
29 other study(ies) available for baclofen and tizanidine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of centrally acting myorelaxants on NMDA receptor-mediated synaptic transmission in the immature rat spinal cord in vitro.
Topics: Animals; Baclofen; Clonidine; Diazepam; In Vitro Techniques; Muscle Relaxants, Central; Rats; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Spinal Nerve Roots; Synaptic Transmission; Tetrodotoxin | 1992 |
Flexor reflex for assessment of common interneurone activity in spasticity.
Topics: Adult; Aged; Anti-Anxiety Agents; Baclofen; Benzodiazepines; Benzodiazepinones; Cerebrovascular Disorders; Clonidine; Electroacupuncture; Electromyography; Female; Hemiplegia; Humans; Interneurons; Male; Middle Aged; Muscle Relaxants, Central; Muscle Spasticity; Reaction Time; Reflex | 1992 |
[The effect of muscle relaxants on the function of the vestibulo-ocular reflex arc].
Topics: Adult; Baclofen; Clonidine; Female; Humans; Male; Muscle Relaxants, Central; Reflex, Vestibulo-Ocular | 1990 |
Tizanidine vs. baclofen in the treatment of spasticity in patients with multiple sclerosis.
Topics: Baclofen; Clonidine; Drug Tolerance; Humans; Multiple Sclerosis; Muscle Spasticity | 1989 |
Myorelaxant effect after intrathecal injection of antispastic drugs in rats.
Topics: Animals; Baclofen; Clonidine; Dose-Response Relationship, Drug; Female; H-Reflex; Injections, Spinal; Male; Midazolam; Muscle Contraction; Muscle Relaxation; Parasympatholytics; Rats; Rats, Mutant Strains; Reflex, Monosynaptic; Time Factors | 1989 |
Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients.
Topics: Adult; Aged; Baclofen; Clonidine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Muscles | 1988 |
Electrophysiological analysis of the mode of action of muscle relaxants in spasticity.
Topics: Baclofen; Clonidine; Diazepam; Electrophysiology; Ethanolamines; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Muscle Spasticity | 1985 |
Selective depression of synaptic transmission of spinal neurones in the cat by a new centrally acting muscle relaxant, 5-chloro-4-(2-imidazolin-2-yl-amino)-2, 1, 3-benzothiodazole (DS103-282).
Topics: Amino Acids; Animals; Baclofen; Cats; Clonidine; Female; Male; Muscle Relaxants, Central; Neurons; Reflex; Spinal Cord; Synapses; Synaptic Transmission | 1982 |
The drug treatment of spasticity.
Topics: Baclofen; Clonidine; Dantrolene; Diazepam; Humans; Muscle Spasticity; Parasympatholytics | 1983 |
Selective antinociceptive effects of tizanidine (DS 103-282), a centrally acting muscle relaxant, on dorsal horn neurones in the feline spinal cord.
Topics: Amino Acids; Analgesics; Animals; Baclofen; Cats; Clonidine; Electric Stimulation; Female; Injections, Intravenous; Iontophoresis; Male; Muscle Relaxants, Central; Naloxone; Neurons; Norepinephrine; Spinal Cord | 1984 |
Double-blind comparison of single doses of DS103-282, baclofen and placebo for suppression of spasticity.
Topics: Adolescent; Adult; Aged; Baclofen; Clonidine; Double-Blind Method; Electromyography; Female; Hemiplegia; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Paralysis; Placebos | 1980 |
The effects of central myorelaxants on synaptically-evoked primary afferent depolarization in the immature rat spinal cord in vitro.
Topics: 2-Amino-5-phosphonovalerate; Adrenergic alpha-Agonists; Animals; Baclofen; Clonidine; Diazepam; Electric Stimulation; Evoked Potentials; Ganglia, Spinal; In Vitro Techniques; Muscle Relaxants, Central; Nerve Fibers; Neurons, Afferent; Rats; Receptors, Adrenergic, alpha-2; Spinal Cord; Synapses | 1994 |
A comparison of the effects of two antispastic drugs, tizanidine and baclofen, on synaptic transmission from muscle spindle afferents to spinal interneurones in cats.
Topics: Afferent Pathways; Animals; Anticonvulsants; Baclofen; Cats; Clonidine; Dose-Response Relationship, Drug; Interneurons; Muscle Spindles; Synaptic Transmission; Time Factors | 1996 |
[Current data on bipolar disorders, epilepsy and spasticity. 4. Neuro-Forum, Dresden].
Topics: Baclofen; Bipolar Disorder; Clonidine; Epilepsy; Female; Humans; Male; Muscle Relaxants, Central; Muscle Spasticity; Spasm | 1999 |
[Current data on bipolar disorders, epilepsy and spasm. 4th Neuro-Forum, Dresden].
Topics: Baclofen; Benzodiazepines; Bipolar Disorder; Clonidine; Epilepsy; Humans; Muscle Relaxants, Central; Paraplegia | 1999 |
[Pharmacology of spasticity. Does therapy remain in deep sleep?].
Topics: Animals; Baclofen; Botulinum Toxins, Type A; Clonidine; Drug Industry; Humans; Injections, Spinal; Muscle Relaxants, Central; Muscle Spasticity; Receptors, Adrenergic, alpha-2; Receptors, GABA-B; Research | 2000 |
Treatment of spasticity.
Topics: Acetates; Amines; Aminopyridines; Baclofen; Benzodiazepines; Botulinum Toxins, Type A; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Memantine; Muscle Spasticity; Paralysis; Rhizotomy | 2002 |
Involuntary jerking of lower half of the body (spinal myoclonus).
Topics: Baclofen; Clonazepam; Clonidine; Diagnosis, Differential; Humans; Lower Extremity; Middle Aged; Myoclonus; Spinal Cord; Spinal Cord Diseases | 2005 |
Drug treatments for spasticity.
Topics: Administration, Oral; Adult; Alcohols; Algorithms; Anti-Dyskinesia Agents; Baclofen; Botulinum Toxins; Child; Clonidine; Decision Trees; Humans; Injections, Intramuscular; Injections, Spinal; Muscle Relaxants, Central; Muscle Spasticity; Patient Selection; Phenol; Safety; Sclerosing Solutions; Treatment Outcome | 2009 |
Adherence associated with oral medications in the treatment of spasticity.
Topics: Administration, Oral; Adult; Baclofen; Clonidine; Dantrolene; Female; Humans; Male; Medication Adherence; Middle Aged; Muscle Relaxants, Central; Muscle Spasticity; Retrospective Studies; Young Adult | 2013 |
[Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
Topics: Aged; Baclofen; Clonidine; Comparative Effectiveness Research; Dantrolene; Female; Humans; Male; Muscle Relaxants, Central; Muscle Spasticity; Muscle Tonus; Recovery of Function; Self Report; Stroke; Stroke Rehabilitation; Tolperisone; Treatment Outcome; Walking | 2013 |
Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
Topics: Administration, Oral; Adolescent; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool; Clonidine; Drug Therapy, Combination; Equinus Deformity; Female; Follow-Up Studies; Humans; Male; Muscle Spasticity; Neuromuscular Agents; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2016 |
Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis.
Topics: Administration, Oral; Aged; Ambulatory Care; Baclofen; Clonidine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Outcome Assessment, Health Care; Pain Measurement; Retrospective Studies; Walking | 2018 |
Trauma-induced adiposis dolorosa (Dercum's disease).
Topics: Accidents, Traffic; Adipose Tissue; Adiposis Dolorosa; Adult; Amitriptyline; Analgesics, Non-Narcotic; Angiomyolipoma; Baclofen; Chronic Pain; Clonidine; Diagnosis, Differential; Humans; Ibuprofen; Male; Muscle Relaxants, Central; Tomography, X-Ray Computed; Upper Extremity | 2018 |
Italian consensus on treatment of spasticity in multiple sclerosis.
Topics: Baclofen; Botulinum Toxins; Clonidine; Consensus; Disease Management; Gabapentin; Humans; Injections, Intramuscular; Italy; Multiple Sclerosis; Muscle Spasticity; Quality of Life; Transcutaneous Electric Nerve Stimulation | 2020 |
Safety of baclofen versus tizanidine for older adults with musculoskeletal pain.
Topics: Aged; Baclofen; Delirium; Female; Humans; Male; Muscle Relaxants, Central; Muscle Spasticity; Musculoskeletal Pain; Retrospective Studies | 2023 |